<qa>  What is the primary purpose of this clinical research study?The primary purpose of this clinical research study is to learn if patients treated with the combination of TaxaneCarboplatin plus Cetuximab CTC have a longer progression-free survival than patients treated with TaxaneCarboplatin TC alone. The safety of this treatment will also be studied. 